Evidence map›Paper›PMID 41501655›Full record

ArticleBMC medical research methodology2026

Innovative statistical method for longitudinal and hierarchical data modeling: the GMEXGBoost method.

Fariba Asadi, Reza Homayounfar, Yaser Mehrali, Chiara Masci, Farid Zayeri

Abstract read
In one paragraph

Article in BMC medical research methodology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fariba AsadiFerdows Faculty of Medical Sciences, Birjand University of Medical Sciences, Birjand, Iran.
Reza HomayounfarNoncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.
Yaser MehraliStatistical Center of Iran, Tehran, Iran.
Chiara MasciDepartment of Economics, Management and Quantitative Methods, University of Milan, Milan, Italy.
Farid ZayeriProteomics Research Center and Department of Biostatistics, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Qods Square, Darband Street, Tehran, Iran. fzayeri@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

INTRODUCTION AND

objectivesOver recent decades, the exponential growth of data, especially in healthcare, has necessitated advanced analytical methods. Conventional machine learning algorithms often assume independence among data points, limiting their effectiveness with longitudinal and hierarchical data. This study introduces a novel algorithm called GMEXGBoost, a methodological extension of generalized mixed-effects models that leverages the boosting framework of XGBoost for estimating fixed effects while simultaneously accounting for random effects. The innovation lies in GMEXGBoost's ability to explicitly incorporate data correlations while retaining the predictive power of boosted trees.

methodsThe GMEXGBoost model was evaluated through extensive simulations and a real-world cohort study, benchmarking against GLMM, GLMMTree, GMERF, and XGBoost. Also, its performance was assessed using predictive mean absolute deviation (PMAD), predictive misclassification rate (PMCR), sensitivity, specificity, accuracy, and AUC. Simulation analyses were conducted using multiple synthetic datasets, each comprising training and testing groups with varying effect structures, including random intercepts and slopes. All computations were performed in RStudio(version 2023.06.0).

resultsOur results indicate that while XGBoost achieved the lowest average errors across most scenarios, GMEXGBoost consistently demonstrated superior stability and accuracy when random-effect variance was large or correlations were strong. Also, in real data, GMEXGBoost outperformed other models in terms of the performance metrics.

conclusionThe GMEXGBoost algorithm, by combining the estimates of the GLMM and XGBoost models, leverages the capabilities of both and delivers improved performance in complex problems. Although it is not universally superior, but demonstrates clear advantages in the analysis of hierarchical and longitudinal datasets with strong correlations. These properties make it a valuable tool for decision-making in healthcare and other domains that involve complex, structured data.

Indexed as

Models, StatisticalAlgorithmsBoosting Machine Learning AlgorithmsComputer SimulationHumansLongitudinal StudiesPrediction AlgorithmsPredictive Learning ModelsBoosted treeGeneralized linear mixed modelLongitudinal and hierarchical data

Identifiers

PMID41501655
PMCPMC12874673

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.